Company

Symbiomix Therapeutics, LLC

Symbiomix Therapeutics, LLC is a biopharmaceutical company developing treatments for women's health, including infectious disease.

About

Founded in 2012 and headquartered in Newark, US, Symbiomix Therapeutics develops biopharmaceutical treatments for women's health, focusing on infectious diseases and microbiome-related conditions. Its products are sold to healthcare providers in North America, Europe, and Asia. Lupin Limited acquired the company in October 2017 for USD 150 mn, including an upfront payment of USD 50 mn and additional time-based payments. Its listed stage is Series A.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in